- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05106244
Remote Real-Time Guidance System in Home Care of Patients With PICC or PORT (RRTGS)
April 2, 2024 updated by: First Affiliated Hospital Xi'an Jiaotong University
The Application of Remote Real-Time Guidance System in Home Care of Patients With PICC or PORT
Clinical treatment of digestive tract tumor patients often need chemotherapy before and after operation, most chemotherapy drugs will cause harm to patients, prone to leakage, leading to tissue necrosis.
The construction of deep venous channels can protect the blood vessels of patients and reduce their pain.
PICC and PORT have become a new clinical treatment technology, and have become the mainstream mode of long-term intravenous indwelling.
Although the central venous catheterization technology has many advantages, it also has some limitations.
Because of its long-term existence, periodic nursing needs to be carried out, such as correct flushing, sealing, replacement of film and so on.
Incorrect care or failure to come to the hospital on time may lead to abnormal use of the catheter or shortening of service life, resulting in some unexpected pain.
Under the influence of COVID-19 's epidemic situation, it becomes more difficult and unrealistic for patients to come to hospital regularly for nursing.
During the epidemic, patients need more safe and effective care at home.
In order to help patients with good central venous catheter nursing at home, this study intends to apply remote professional real-time guidance technology to home nursing care of PICC and PORT tumor patients.
Through on-site practical operation training, video explanation materials of long-distance on-line decomposition steps and real-time telephone audio connection guidance are provided to enable patients' families to quickly learn to master nursing techniques, so as to achieve safe and effective self-care at home.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
From January 2022 to October 2022, 200 patients with digestive tract tumors with indwelling PICC or PORT in the inpatient department of oncology surgery in First Affiliated Hospital of Xian Jiaotong University were randomly divided into control group (hospital nursing mode) and experimental group (family self-nursing mode) .
The specific methods were as follows: 2-1 the control group adopted regular nursing mode after catheterization.
The patients were mainly given on-site catheterization nursing by specialist nurses, and health consultation and guidance were carried out during the period of catheterization.
2-2 the experimental group adopted the family self-nursing mode, mainly by the patients' family members to observe the catheter and do regular nursing, and the specialist nurses provided remote real-time online guidance to monitor the family nursing of central venous catheter.
The specific operation procedures are as follows: (1) make nursing videos recorded and reviewed by central venous catheter specialist nurses (video production is carried out separately for different central venous access devices from different manufacturers, as well as follow-up training steps).
(2) evaluate the nursing operation ability of the patients' family members and carry out relevant training and health education, including hand washing, aseptic concept, matters needing attention in removing the film, flushing and sealing techniques, and local observation points at the puncture point, etc., repeatedly strengthen the training of key links and conduct assessment until the participants are qualified; (3) distribute nursing guidance prescriptions and maintenance manuals for central venous catheters.
(4) provide online simulated realistic nursing video materials, nursing video materials are decomposed in detailed steps, each step is equipped with detailed language explanation and explanation, and the key links are reminders or warnings.
It is convenient for patients' families to learn and master quickly; (5) provide real-time telephone audio and video connection to complete remote nursing guidance.
(6) set up a home nursing volunteer service group, which is composed of nursing team members led by central venous catheter specialist nurses, establish a doctor-patient exchange group by using Wechat and other media, and provide nursing outpatient information of each central venous catheter in the area.
Improve family nursing failure remedial measures, provide necessary guidance and help, and timely feedback.
The normal service life of the catheter, the infection rate of the catheter puncture point, the catheter occlusion rate, the nursing experience and satisfaction of the patients and their families were compared between the two groups.
Statistical processing: the data were analyzed by SPSS22.0 software.
The measurement data are expressed as mean ± standard deviation, t-test is used, counting data is expressed as rate (%), and 2 test or Fisher exact probability method is used.
Study Type
Interventional
Enrollment (Estimated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yong Zhang, Doctor
- Phone Number: 0086-13709110938
- Email: 13709110938@163.com
Study Contact Backup
- Name: XinRui Zhou, Bachelor's Degree
- Phone Number: 0086-15102937212
- Email: 3022658878@qq.com
Study Locations
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 710061
- Recruiting
- First Affiliated Hospital of Xian Jiaotong University
-
Contact:
- Yong Zhang, Doctor
- Phone Number: 0086-13709110938
- Email: 13709110938@163.com
-
Contact:
- XinRui Zhou, Bachelor's Degree
- Phone Number: 0086-15102937212
- Email: 3022658878@qq.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients diagnosed with gastric cancer or colorectal cancer with indwelling central venous catheter (PICC or PORT)
- Age ≥18 years and ≤75 years
- Normal cognitive function
- Be informed of and actively cooperate with this study
Exclusion Criteria:
- Suffering from psychological disorders and not able to communicate normally
- Unable to cooperate due to other factors
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: family self-nursing mode
|
the experimental group adopted the family self-nursing mode, mainly by the patients' family members to observe the catheter and do regular nursing, and the specialist nurses provided remote real-time online guidance to monitor the family nursing of central venous catheter.
The procedures are as follows: (1) make nursing videos recorded by central venous catheter specialist nurses; (2) evaluate the nursing operation ability of the patients' family members and carry out relevant training and health education, repeat until they are qualified; (3) distribute nursing guidance prescriptions and maintenance manuals for central venous catheters; (4) provide online simulated realistic nursing video materials; (5) provide real-time telephone audio and video connection to complete remote nursing guidance.
(6) set up a home nursing volunteer service group, establish a doctor-patient exchange group by using Wechat and other media.
|
No Intervention: hospital nursing mode
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Average level of service life of the catheter
Time Frame: up to 10 months
|
Average length of service life of PICC or PORT
|
up to 10 months
|
Incidence of puncture point infection
Time Frame: up to 10 months
|
Incidence of puncture point infection of PICC or PORT
|
up to 10 months
|
Incidence of catheter occlusion
Time Frame: up to 10 months
|
Incidence of catheter occlusion of PICC or PORT
|
up to 10 months
|
Degree of satisfaction of patients and their families
Time Frame: up to 10 months
|
a satisfaction survey of patients and their families, using a self-designed questionnaire.
|
up to 10 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Yong Zhang, Doctor, First Affiliated Hospital of Xian Jiaotong University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2022
Primary Completion (Estimated)
August 30, 2024
Study Completion (Estimated)
August 30, 2024
Study Registration Dates
First Submitted
September 16, 2021
First Submitted That Met QC Criteria
October 21, 2021
First Posted (Actual)
November 3, 2021
Study Record Updates
Last Update Posted (Actual)
April 3, 2024
Last Update Submitted That Met QC Criteria
April 2, 2024
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- XJTU1AF2021LSK-300
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Neoplasms
-
Novartis PharmaceuticalsActive, not recruitingNeoplasms, Gastrointestinal TractChina, Canada, Estonia, Italy, Turkey, Argentina, Israel, Netherlands, Poland, Russian Federation, Thailand, Brazil, Chile, Hong Kong, Hungary, India, Mexico, Peru, Taiwan, Ukraine, United States, Korea, Republic of, Puerto Rico
-
Shanghai Juncell TherapeuticsShanghai 10th People's HospitalRecruiting
-
Sun Yat-sen UniversityUnknownGastrointestinal CancersChina
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompleted
-
Peking University Cancer Hospital & InstituteActive, not recruitingGastrointestinal CancerChina
-
Brigette MaRecruiting
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdJiangsu Alphamab Biopharmaceuticals Co., LtdRecruitingAdvanced Gastrointestinal TumorsChina
-
Boehringer IngelheimCompletedGastrointestinal Cancer, MetastaticBelgium, United States, France, Japan, China
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Henan Cancer HospitalUnknownAdvanced Gastrointestinal TumorsChina
Clinical Trials on Real-Time Guidance of Home Care for Patients with PICC or PORT
-
Washington University School of MedicineTerminated
-
Norwegian Institute of Public HealthUniversity of Oslo; Oslo University Hospital; Oslo MunicipalityActive, not recruitingHip Fractures | Fall Injury
-
University of WashingtonNational Institute on Drug Abuse (NIDA); Kaiser PermanenteCompleted
-
Memorial Sloan Kettering Cancer CenterPfizer; Dana-Farber Cancer Institute; University of Pittsburgh; University of VirginiaCompletedNeurofibromatosis | Meningioma | CNS Cancer | Hemangioblastoma | Intracranial HemangiopericytomaUnited States